J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Disclosure Of Related Party Transactions Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half Year Ended March 31, 2023
Disclosure of related party transactions under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for half year ended March 31, 2023
JB Chemicals Q4 results: PAT rise by 3.5% to 88 crore, revenue up 22% on strong growth across verticals
JB Chemicals posted double-digit growth in revenue due to strong performance across verticals. Also, EBITDA climbed impressively. The company, however, saw a single-digit upside in PAT. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on audited consolidated financial results for the quarter and year ended on March 31, 2023 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - (I) The Board Considered And Approved Sub-Division/Split Of Existing Equity Shares (Ii) Recommended A Final Dividend Of Rs. 9.25 (462.50 %) Per Equity Share
(I) The Board considered and approved sub-division/split of existing equity shares (ii) Recommended a final dividend of Rs. 9.25 (462.50 %) per equity share J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Board Meeting Outcome for Outcome Of The Board Meeting
Outcome of the Board meeting- Audited standalone and consolidate financial results for the year ended on March 31, 2023 J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended on March 31, 2023. J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors/analysts call with management